{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T20:29:50Z","timestamp":1790281790417,"version":"4.1.0"},"reference-count":56,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Autoimmunity Reviews"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.autrev.2018.02.003","type":"journal-article","created":{"date-parts":[[2018,5,3]],"date-time":"2018-05-03T09:45:41Z","timestamp":1525340741000},"page":"709-714","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Cytokine markers of B lymphocytes in minor salivary gland infiltrates in Sj\u00f6gren's syndrome"],"prefix":"10.1016","volume":"17","author":[{"given":"Erika P.","family":"Navarro-Mendoza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Aguirre-Valencia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iv\u00e1n","family":"Posso-Osorio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shirley Vanessa","family":"Correa-Forero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel-Felipe","family":"Torres-Cutiva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Loaiza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel J.","family":"Tob\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.autrev.2018.02.003_bb0005","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1006\/clin.1994.1123","article-title":"Sj\u00f6gren's syndrome: autoimmune epithelitis","volume":"72","author":"Moutsopoulos","year":"1994","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1016\/j.autrev.2018.02.003_bb0010","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.autrev.2016.09.017","article-title":"Intersticial lung disease in primary Sjogren's syndrome","volume":"16","author":"Roca","year":"2017","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2018.02.003_bb0015","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s00296-014-3097-9","article-title":"Frequent involvement of central nervous system in primary Sj\u00f6gren syndrome","volume":"35","author":"Moreira","year":"2015","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.autrev.2018.02.003_bb0020","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.autrev.2016.12.006","article-title":"Sjogren's syndrome \u2013 associated myositis with germinal center-like structure","volume":"16","author":"Espitia-Thibault","year":"2017","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2018.02.003_bb0025","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.berh.2004.03.007","article-title":"Laboratory testing in autoimmune rheumatic diseases","volume":"18","author":"Sheldon","year":"2004","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/j.autrev.2018.02.003_bb0030","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.2174\/138920112802273100","article-title":"B-lymphocytes govern the pathogenesis of Sj\u00f6gren's syndrome","volume":"13","author":"Youinou","year":"2012","journal-title":"Curr Pharm Biotechnol"},{"key":"10.1016\/j.autrev.2018.02.003_bb0035","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.jaut.2009.10.004","article-title":"Characteristics of the minor salivary gland infiltrates in Sj\u00f6gren's syndrome","volume":"34","author":"Christodoulou","year":"2010","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2018.02.003_bb0040","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.smim.2006.04.006","article-title":"BAFF, APRIL and their receptors: structure, function and signaling","volume":"18","author":"Bossen","year":"2006","journal-title":"Semin Immunol"},{"key":"10.1016\/j.autrev.2018.02.003_bb0045","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1084\/jem.189.11.1747","article-title":"BAFF, a novel ligand of the tumor necrosis factor family, stimulates B cell growth","volume":"189","author":"Schneider","year":"1999","journal-title":"J Exp Med"},{"key":"10.1016\/j.autrev.2018.02.003_bb0050","doi-asserted-by":"crossref","first-page":"3187","DOI":"10.1002\/art.11311","article-title":"Cellular basis of ectopic germinal center formation and autoantibody production in the target organ of patients with Sjogren's syndrome","volume":"48","author":"Salomonsson","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2018.02.003_bb0055","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.clim.2005.06.016","article-title":"Distinct profiles of Sjogren's syndrome patients with ectopic salivary gland germinal centers revealed by serum cytokines and BAFF","volume":"117","author":"Szodoray","year":"2005","journal-title":"Clin Immunol"},{"key":"10.1016\/j.autrev.2018.02.003_bb0060","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1136\/ard.62.2.168","article-title":"The level of BLyS (BAFF) correlates with the titre of autoantibodies in human Sjogren's syndrome","volume":"6","author":"Mariette","year":"2003","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2018.02.003_bb0065","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.autrev.2015.03.004","article-title":"Clinical picture, outcome and predictive factors of lymphoma in Sj\u04e7gren syndrome","volume":"14","author":"Papargeorgiou","year":"2015","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2018.02.003_bb0070","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1159\/000082106","article-title":"The BAFF\/APRIL system: an important player in systemic rheumatic diseases","volume":"8","author":"Mackay","year":"2005","journal-title":"Curr Dir Autoimmun"},{"key":"10.1016\/j.autrev.2018.02.003_bb0075","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1146\/annurev.immunol.21.120601.141152","article-title":"Baff and April: a tutorial on B cell survival","volume":"21","author":"Mackay","year":"2003","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.autrev.2018.02.003_bb0080","doi-asserted-by":"crossref","first-page":"3561","DOI":"10.4049\/jimmunol.0800933","article-title":"B cell receptor and baff receptor signaling regulation of B cell homeostasis","volume":"183","author":"Kahn","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2018.02.003_bb0085","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.jaut.2014.02.004","article-title":"Specific forms of BAFF favor BAFF receptor-mediated epithelial cell survival","volume":"51","author":"Lahiri","year":"2014","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2018.02.003_bb0090","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jaut.2015.04.007","article-title":"Deleting the BAFF receptor TACI protects against systemic lupus erythematosus without extensive reduction of B cell numbers","volume":"61","author":"Figgett","year":"2015","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2018.02.003_bb0095","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1093\/rheumatology\/ker016","article-title":"Absence of up-regulation for a proliferation-inducing ligand in Sjogrens sialadenitis lesions","volume":"50","author":"Lombardi","year":"2011","journal-title":"Rheumatology"},{"key":"10.1016\/j.autrev.2018.02.003_bb0100","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1093\/intimm\/dxq047","article-title":"Finding the right niche: B-cell migration in the early phases of T-dependent antibody responses","volume":"22","author":"Pereira","year":"2010","journal-title":"Int Immunol"},{"key":"10.1016\/j.autrev.2018.02.003_bb0105","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1182\/blood.V84.3.830.830","article-title":"Expression of the G-protein-coupled receptor BLR1 defines mature, recirculating B cells and a subset of T-helper memory cells","volume":"8","author":"Forster","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2018.02.003_bb0110","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s12865-015-0068-1","article-title":"CXCL13 antibody for the treatment of autoimmune disorders","volume":"16","author":"Klimatcheva","year":"2015","journal-title":"BMC Immunol"},{"key":"10.1016\/j.autrev.2018.02.003_bb0115","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1189\/jlb.0113036","article-title":"CXCL13 is elevated in Sj\u00f6gren's syndrome in mice and humans and is implicated in disease pathogenesis","volume":"94","author":"Kramer","year":"2013","journal-title":"J Leukoc Biol"},{"key":"10.1016\/j.autrev.2018.02.003_bb0120","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1046\/j.1365-3083.2002.01058.x","article-title":"Expression of the B cell-attracting chemokine CXCL13 in the target organ and autoantibody production in ectopic lymphoid tissue in the chronic inflammatory disease Sj\u00f6gren's syndrome","volume":"55","author":"Salomonsson","year":"2002","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.autrev.2018.02.003_bb0125","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1002\/sita.200600086","article-title":"Updating interleukin-6 classic- and trans-signaling","volume":"6","author":"Scheller","year":"2006","journal-title":"Signal Transduct"},{"key":"10.1016\/j.autrev.2018.02.003_bb0130","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1097\/01.CCM.0000203108.60429.DF","article-title":"The prevention and treatment of sepsis: is interleukin-6 a drug target or a drug?","volume":"34","author":"Fink","year":"2006","journal-title":"Crit Care Med"},{"key":"10.1016\/j.autrev.2018.02.003_bb0135","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1056\/NEJM199902113400607","article-title":"Acute-phase proteins and other systemic responses to inflammation","volume":"34","author":"Gabay","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/j.autrev.2018.02.003_bb0140","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s002960050070","article-title":"Increased salivary interleukin-6 levels in patients with primary Sj\u00f6gren's syndrome","volume":"18","author":"Tishler","year":"1999","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.autrev.2018.02.003_bb0145","first-page":"1089","article-title":"Salivary and serum interleukin 6 in primary Sj\u00f6gren's syndrome","volume":"24","author":"Grisius","year":"1997","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2018.02.003_bb0150","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0045689","article-title":"Skewed production of IL-6 and TGFb by cultured salivary gland epithelial cells from patients with Sj\u00f6gren's syndrome","volume":"7","author":"Kawanami","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.autrev.2018.02.003_bb0155","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.biochi.2015.11.005","article-title":"Modular organization of Interleukin-6 and Interleukin-11 \u03b1-receptors","volume":"119","author":"Nitz","year":"2015","journal-title":"Biochimie"},{"key":"10.1016\/j.autrev.2018.02.003_bb0160","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1136\/ard.2008.091256","article-title":"Interleukin 6 and its soluble receptor in a central role at the neuroimmunoendocrine interface in Sj\u00f6gren syndrome: an explanatory interventional study","volume":"68","author":"d'Elia","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2018.02.003_bb0165","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.jaut.2009.02.013","article-title":"The weight of interleukin-6 in B cell-related autoimmune disorders","volume":"32","author":"Youinou","year":"2009","journal-title":"J Autoimmun"},{"key":"10.1016\/j.autrev.2018.02.003_bb0170","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/ni.3153","article-title":"IL-6 as a keystone cytokine in health and disease","volume":"16","author":"Hunter","year":"2015","journal-title":"Nat Immunol"},{"key":"10.1016\/j.autrev.2018.02.003_bb0175","doi-asserted-by":"crossref","first-page":"4883","DOI":"10.1016\/j.febslet.2010.08.022","article-title":"Receptors and signaling mechanisms for B-lymphocyte activation, proliferation and differentiation--insights from both in vivo and in vitro approaches","volume":"584","author":"Maddaly","year":"2010","journal-title":"FEBS Lett"},{"key":"10.1016\/j.autrev.2018.02.003_bb0180","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/j.autrev.2016.03.004","article-title":"Primary Sjogren's syndrome: clinical phenotypes, outcome and the development of biomarkers","volume":"15","author":"Goules","year":"2016","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.autrev.2018.02.003_bb0185","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1038\/nrc1169","article-title":"The role of FLT3 in haematopoietic malignancies","volume":"3","author":"Stirewalt","year":"2003","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.autrev.2018.02.003_bb0190","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1080\/08977190410001700989","article-title":"FLT3: receptor and ligand","volume":"22","author":"Drexler","year":"2004","journal-title":"Growth Factors"},{"key":"10.1016\/j.autrev.2018.02.003_bb0195","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1182\/blood-2002-02-0492","article-title":"The roles of FLT3 in hematopoiesis and leukemia","volume":"100","author":"Gilliland","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.autrev.2018.02.003_bb0200","doi-asserted-by":"crossref","first-page":"3447","DOI":"10.1002\/art.27611","article-title":"The Fms-like tyrosine kinase 3 ligand, a mediator of B cell survival, is also a marker of lymphoma in primary Sj\u00f6gren's syndrome","volume":"62","author":"Tob\u00f3n","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2018.02.003_bb0205","doi-asserted-by":"crossref","first-page":"3218","DOI":"10.1002\/art.38129","article-title":"Role of Fms-like tyrosine kinase 3 ligand as a potential biologic marker of lymphoma in primary Sj\u00f6gren's syndrome","volume":"65","author":"Tob\u00f3n","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.autrev.2018.02.003_bb0210","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1016\/j.str.2008.06.005","article-title":"Structure of IL-22 bound to its high-affinity IL-22R1 chain","volume":"16","author":"Jones","year":"2008","journal-title":"Structure"},{"key":"10.1016\/j.autrev.2018.02.003_bb0215","doi-asserted-by":"crossref","first-page":"11024","DOI":"10.1073\/pnas.1503315112","article-title":"IL-22 regulates lymphoid chemokine production and assembly of tertiary lymphoid organs","volume":"112","author":"Barone","year":"2015","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.autrev.2018.02.003_bb0220","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1136\/ard.2011.154013","article-title":"Potential involvement of IL-22 and IL-22-producing cells in the inflamed salivary glands of patients with Sj\u00f6gren's syndrome","volume":"71","author":"Ciccia","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.autrev.2018.02.003_bb0225","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1007\/s00109-016-1391-6","article-title":"Biological and pathological activities of interleukin-22","volume":"94","author":"Perusina Lanfranca","year":"2016","journal-title":"J Mol Med"},{"key":"10.1016\/j.autrev.2018.02.003_bb0230","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1016\/j.jmb.2008.07.046","article-title":"IL-22R, IL-10R2, and IL-22BP binding sites are topologically juxtaposed on adjacent and overlapping surfaces of IL-22","volume":"382","author":"Wu","year":"2008","journal-title":"J Mol Biol"},{"key":"10.1016\/j.autrev.2018.02.003_bb0235","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/mi.2015.83","article-title":"IL-22BP is produced by eosinophils in human gut and blocks IL-22 protective actions during colitis","volume":"9","author":"Martin","year":"2016","journal-title":"Mucosal Immunol"},{"key":"10.1016\/j.autrev.2018.02.003_bb0240","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.3899\/jrheum.131292","article-title":"Increased urinary interleukin 22 binding protein levels correlate with lupus nephritis activity","volume":"41","author":"Yang","year":"2014","journal-title":"J Rheumatol"},{"key":"10.1016\/j.autrev.2018.02.003_bb0245","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1586\/1744666X.2014.884461","article-title":"The role of innate and lymphoid IL-22-producing cells in the immunopathology of primary Sj\u00f6gren's syndrome","volume":"10","author":"Ciccia","year":"2014","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.autrev.2018.02.003_bb0250","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1136\/jcp.21.5.656","article-title":"Labial salivary gland biopsy in Sj\u00f6gren's disease","volume":"21","author":"Chisholm","year":"1968","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.autrev.2018.02.003_bb0255","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/0030-4220(74)90160-1","article-title":"Minor salivary gland involvement in Sjogren's syndrome","volume":"37","author":"Tarpley","year":"1974","journal-title":"Oral Surg Oral Med Oral Pathol"},{"key":"10.1016\/j.autrev.2018.02.003_bb0260","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/0030-4220(74)90417-4","article-title":"The histopathology of Sj\u00f6gren's syndrome in labial salivary gland biopsies","volume":"37","author":"Greenspan","year":"1974","journal-title":"Oral Surg Oral Med Oral Pathol"},{"key":"10.1016\/j.autrev.2018.02.003_bb0265","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.semarthrit.2014.05.015","article-title":"Is minor salivary gland biopsy more than a diagnostic tool in primary Sj\u00f6gren's syndrome? Association between clinical, histopathological, and molecular features: a retrospective study","volume":"44","author":"Carubbi","year":"2014","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.autrev.2018.02.003_bb0270","doi-asserted-by":"crossref","first-page":"190","DOI":"10.3346\/jkms.2016.31.2.190","article-title":"The significance of ectopic germinal centers in the minor salivary gland of patients with Sj\u00f6gren's syndrome","volume":"31","author":"Lee","year":"2016","journal-title":"J Korean Med Sci"},{"key":"10.1016\/j.autrev.2018.02.003_bb0275","doi-asserted-by":"crossref","first-page":"5130","DOI":"10.4049\/jimmunol.180.7.5130","article-title":"CXCL13, CCL21, and CXCL12 expression in salivary glands of patients with Sjogren's syndrome and MALT lymphoma: association with reactive and malignant areas of lymphoid organization","volume":"180","author":"Barone","year":"2008","journal-title":"J Immunol"},{"key":"10.1016\/j.autrev.2018.02.003_bb0280","doi-asserted-by":"crossref","first-page":"3540","DOI":"10.4049\/jimmunol.0803588","article-title":"Ectopic germinal centers are rare in Sjogren's syndrome salivary glands and do not exclude autoreactive B cells","volume":"182","author":"Le Pottier","year":"2009","journal-title":"J Immunol"}],"container-title":["Autoimmunity Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997218301125?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568997218301125?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,17]],"date-time":"2019-10-17T10:41:58Z","timestamp":1571308918000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568997218301125"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":56,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["S1568997218301125"],"URL":"https:\/\/doi.org\/10.1016\/j.autrev.2018.02.003","relation":{},"ISSN":["1568-9972"],"issn-type":[{"value":"1568-9972","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cytokine markers of B lymphocytes in minor salivary gland infiltrates in Sj\u00f6gren's syndrome","name":"articletitle","label":"Article Title"},{"value":"Autoimmunity Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.autrev.2018.02.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}